naphthalene
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2023 (NCT06086522)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Loading structure…
SMILES
c1ccc2ccccc2c1- Mol. weight
- 128.17 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4640542 ↗
- ChEMBLCHEMBL16293 ↗
Also known as
- naphthalene
- naphthalene
- naphthalin
- naphthalin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06086522 | Phase 1 | Nov 1, 2023 | Qualigen Theraputics, Inc., Translational Drug Development |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Qualigen Theraputics, Inc. | For profit | 1 | 1 | 1 | 2023 |
| Translational Drug Development | For profit | 1 | 0 | 1 | 2023 |
2 organizations
Page 1 / 1